For many patients, this shift alone is significant enough to noticeably change their daily eating patterns before the medication even reaches full therapeutic effect
Gastrointestinal disorders ( mild-to-moderate nausea and vomiting) were the most common adverse events, as it was seen in 45 patients (80%) in the liraglutide group and 14 patients (54%) in the placebo group Table 3
"Carnitine", nih , Retrieved 1/2/2022
The feeling of this drug is not as good as it should be could be due to this substitution, and not obvious to the patient
Insulin Secretagogues Taking retatrutide alongside insulin secretagogues, like sulfonylureas or meglitinides, can increase the likelihood of hypoglycemia
Incidence of cataract operations in Finnish male smokers unaffected by alpha tocopherol or beta carotene supplements